Evelo biosciences inc.

Major-Pharmaceuticals

EVLO


620 Memorial Drive
Cambridge , MA 02139

Executive/
Director

Price

  • Last Close
  • $ 0.18
    $ -0.08 -30.59 %
    Jun 29, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 11,655,027
  • Market Cap Full
  • $ 3.4M
  • Shares Outstanding
  • 18.9M
    Nov 6, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - -38.5% -5% -10.5% -44.2% -88.8% -
Q2 - - - -27.4% 10.6% 4% 23.2% -37.8% -2.2% -
Q3 - - - 1.8% -35.7% 8% -48.8% -1% - -
Q4 - - - 10.9% -31.6% 159.6% -13.8% -23% - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 -35.4% -40.4% -70.8% -14.9% -11% 29.2% - - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%-68%198%-51%-73%-89%0%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - - -3.29 -0.64 -0.71 -0.55 -0.56 -4.60
Q2 - - - -0.85 -0.65 -0.63 -0.59 -0.4 -3.78
Q3 - - - -0.5 -0.67 -0.45 -0.63 -0.28 -0.71
Q4 - - - 1.86 -0.71 -0.58 -0.54 -1.40 -
A 0 0 0 -2.8 -2.7 -2.4 -2.3 -1.3 -9.09

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 31.9 32.2 53.3 53.6 110.9
Jun 31.7 32 32.3 53.4 53.7 112
Sep 31.7 32.1 46.1 53.4 108 18.8
Dec 31.8 32.1 46.2 53.5 109.6 18.9

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - 0.4 0.2 0.1
Debt – Equity Ratio - - 1 0.3 0.1
Interest Coverage -15.4 -16.4 -46 86 58
Equity multiplier - - 0.6 0.2 0.1